Abbott's Simcor gains approval

Libertyville Township-based Abbott received U.S. Food and Drug Administration approval for two new dosage strengths of Simcor, a cholesterol medication.

The new dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release.

Simcor is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin.